Form D · Biotechnology
Swan NeuroTech, Inc.
Canonsburg, PA · CIK 0001807373
Offering snapshot reported Apr 2, 2024 · SEC filing
- Reported sold
- $95K Indefinite offering
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 18, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 2, 2024 | Initial | $95,000 | No comparison | 7 | SEC filing |
| Mar 26, 2020 | Initial | $80,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-509386
Source: Form D, filed Apr 2, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arta Kelmendi Doko | Director |
| Jeremy Kimmel | Executive |
| Kacey Marra | Director |
| Ben Schilling | Executive |
| David S Smith | Executive |
| Kia Washington | Director |
| Tony Windebank | Director |
| Steve Winowich | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1007 Fawn Valley Drive
Canonsburg, PA, 15317
Canonsburg, PA, 15317